Roche Giving WHO More Tamiflu
Written by Stuart Stevens| Wednesday, 13 May 2009| There are 0 comments
The manufacturer of the influenza medication Tamiflu has announced that it is to donate 5.65 million packets of the drug to the World Health Organisation in order to boost stockpiles that have already been utilised in dealing with the recent swine H1N1 influenza virus.
The World Health Organisation has a special rapid response stockpile which is designed to be flown to anywhere in the world at a moment's notice should it be required to help poorer people unable to get their hands on the Tamiflu drug. The World Health Organisation also has a special stockpile of 650,000 child courses of Tamiflu for the same purpose. In fact they have already started to distribute its Tamiflu to 72 individual nations who require it.
Roche, the Swiss pharmaceutical company that manufactures the Tamiflu influenza drug has promised to boost production to manufacture 110 million Tamiflu courses in five months and has pledged to produce 36 million courses every single month by the end of 2009 if it is required. Roche's global pandemic preparedness task force explained that provided that governments made a commitment to increasing their pandemic stockpiles of the Tamiflu they would continue to ramp up the production to meet the demand.
At present the only two drugs which are known to have a positive beneficial effect on treating the swine influenza virus are Tamiflu and Relenza made by GlaxoSmithKline. Tamiflu and Relenza go by the scientific names of oseltamivir and zanamivir.
The United Kingdom has a huge stockpile of influenza drugs including Tamiflu and Relenza which is designed to be used where it is needed. Many individuals have however decided to purchase their own supplies of the drug for themselves and their families.Tamiflu and Relenza are both prescription medications which should not be thought of as an influenza vaccine but as medicines to take when the symptoms of flu appear.